If you’re considering Spravato (esketamine) for treatment-resistant depression, one of your most pressing questions are likely “how long will I stay on Spravato?”, “what does the Spravato timeline look like?”. These are important considerations as you weigh your treatment options.
Spravato represents a breakthrough in depression treatment, offering hope for individuals who haven’t found relief with traditional antidepressants. At Clearwave Psychiatry and TMS Medical, we’re committed to providing innovative, evidence-based care that helps our patients achieve lasting mental wellness. Understanding the treatment timeline can help you make informed decisions about your care and set realistic expectations for your healing journey.
The duration of Spravato treatment varies significantly from person to person, typically ranging from several months to over a year. Your individual timeline will depend on factors like treatment response, symptom severity, and your provider’s clinical judgment. Let’s explore what you can expect throughout this process.
Key Takeaways:
🧠 1. Spravato Offers Hope for Treatment-Resistant Depression
📅 2. Treatment Duration Is Highly Individualized
🧪 3. Two Phases of Treatment
✅ 4. Signs You May Be Ready to Taper Off
🔄 5. Tapering and Post-Treatment Monitoring
What Is Spravato and How Does It Work?
Spravato is an FDA-approved nasal spray containing esketamine, a derivative of ketamine. Unlike traditional antidepressants that target serotonin, norepinephrine, or dopamine systems, Spravato works on the brain’s NMDA receptors. This unique mechanism can help restore neural connections and provide rapid relief from depression symptoms.
The medication is administered in a clinical setting under medical supervision. After receiving the nasal spray, patients remain in the clinic for monitoring, as Spravato can cause side effects like dissociation, dizziness, and changes in blood pressure.
Who Is Spravato For?
Spravato is specifically approved for adults with treatment-resistant depression—meaning you haven’t responded adequately to at least two different antidepressant medications. It’s also approved for adults with major depressive disorder who are experiencing acute suicidal ideation or behavior.
This treatment isn’t a first-line option. Your healthcare provider will typically recommend Spravato after other treatments haven’t provided sufficient relief. Candidates for Spravato treatment undergo thorough evaluation to ensure they’re appropriate for this specialized therapy.
The Spravato Treatment Timeline
Induction Phase
The induction phase involves intensive treatment sessions designed to establish therapeutic benefits. During this initial period, you’ll receive Spravato twice weekly for the first four weeks. This frequent dosing schedule helps build therapeutic levels in your system and allows your healthcare team to monitor your response closely.
Many patients begin noticing improvements within the first few weeks of treatment. You might experience better mood, increased energy, or improved sleep patterns. However, some individuals may need several weeks before seeing significant changes. Your provider will track your progress using standardized depression rating scales and regular check-ins.
Maintenance Phase
After completing the induction phase, successful responders typically transition to a maintenance schedule. Initially, this usually means weekly sessions, though the frequency may eventually decrease to every other week based on your individual response and clinical needs.
The maintenance phase duration varies considerably among patients. Some people may need maintenance treatment for several months, while others benefit from longer-term therapy extending a year or more. Your provider will regularly assess your symptoms, functioning, and overall well-being to determine the optimal schedule for your situation.
How Long Will I Stay on Spravato?
There’s no standard answer to this question because depression treatment is highly individualized. Clinical studies have followed patients for varying lengths of time, with some research extending beyond two years. However, your personal treatment duration will depend on several factors:
Your response to treatment plays a crucial role in determining duration. Patients who achieve significant symptom improvement may continue maintenance therapy to preserve their gains. Those with partial responses might adjust their treatment plan or explore additional interventions.
The severity and chronicity of your depression also influence treatment length. Individuals with long-standing, severe depression may benefit from extended treatment periods. Your history of depression episodes, previous treatment responses, and overall mental health stability all factor into duration decisions.
Personal circumstances and goals matter too. Some patients prefer longer maintenance periods for extra stability, while others may want to minimize treatment duration once they achieve symptom remission.
Signs You May Be Ready to Taper Off
Discontinuing Spravato isn’t a decision made lightly. Your healthcare provider will look for several positive indicators before considering a reduction in treatment frequency or complete discontinuation.
Sustained symptom improvement over several months is typically necessary before tapering begins. This means maintaining stable mood, energy levels, sleep patterns, and overall functioning without significant depression symptoms.
Your ability to manage stress and life challenges effectively is another important factor. If you’re successfully navigating work, relationships, and daily responsibilities while maintaining your mental health, this suggests readiness for potential treatment reduction.
Many providers prefer to see patients maintain stability through challenging periods—such as seasonal changes, work stress, or personal difficulties—before reducing treatment frequency. This helps ensure that your improvement isn’t just temporary.
What Happens After Spravato?
When you and your provider decide to reduce or discontinue Spravato, the process typically involves gradual tapering rather than abrupt cessation. You might transition from weekly to biweekly sessions, then monthly, before stopping completely.
Continued monitoring remains essential during this transition period. Your provider will schedule regular follow-up appointments to assess your mental health status and watch for any signs of symptom return. Many patients continue with psychotherapy, other medications, or lifestyle interventions to maintain their progress.
Some individuals may need to resume Spravato if symptoms return. This doesn’t represent treatment failure—depression can be a chronic condition requiring ongoing management. Your healthcare team will work with you to develop comprehensive relapse prevention strategies.
Why Choose Clearwave for Spravato Treatment?
At Clearwave, we understand that Spravato treatment is a significant commitment requiring expert care and ongoing support. Our experienced team provides comprehensive evaluation, personalized treatment planning, and continuous monitoring throughout your journey.
We create individualized treatment timelines based on your unique needs, response patterns, and personal goals. Our providers maintain regular communication with you about your progress and any concerns that arise during treatment.
Our commitment extends beyond medication administration. We offer integrated care that may include psychotherapy, lifestyle counseling, and coordination with your other healthcare providers to ensure comprehensive mental health support.
Moving Forward with Confidence
The decision to pursue Spravato treatment involves many considerations, including understanding the time commitment involved. While treatment duration varies among individuals, most patients can expect several months to over a year of therapy to achieve and maintain optimal results.
Working with experienced providers who can guide you through each phase of treatment makes this journey more manageable. At Clearwave, we’re here to support you every step of the way, from initial evaluation through maintenance therapy and beyond.
If you’re considering Spravato for treatment-resistant depression, contact Clearwave to schedule a consultation. Our team can help you understand whether this innovative treatment might be right for your situation and develop a personalized care plan that supports your mental health goals.
Looking for TMS treatment options in your New York State area? We are a proudly New York State mental health facility with clinics in Poughkeepsie, Middletown, Valhalla, Nanuet, Garden City, Latham and Hauppauge.
